Impact of safety-related regulatory action on drug use in ambulatory care in the Netherlands. (Q47947189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Impact of safety-related regulatory action on drug use in ambulatory care in the Netherlands (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

S Piening

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

K C Reber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

J E Wieringa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

S M J M Straus

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

P A de Graeff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

F M Haaijer-Ruskamp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

1 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

838-845

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22472991%20AND%20SRC:MED&resulttype=core&format=json

Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Detection, verification, and quantification of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Timing of new black box warnings and withdrawals for prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Communication of medical product risk: how effective is effective enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Lopinavir/Ritonavir: a review of its use in the management of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Knowledge, patterns of care, and outcomes of care for generalists and specialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

A study of compliance with FDA recommendations for pemoline (Cylert).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Research designs for studies evaluating the effectiveness of change and improvement strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

A new look at the statistical model identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Estimating the Dimension of a Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

Impact of implementing alerts about medication black-box warnings in electronic health records

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

7 January 2021

European perspective on risk management and drug safety

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

7 January 2021

Drug labeling revisions-guaranteed to fail?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

7 January 2021

Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

7 January 2021

Cisapride and fatal arrhythmia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

7 January 2021

Segmented regression analysis of interrupted time series studies in medication use research

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.308

7 January 2021